Home Other Building Blocks 866541-93-7
866541-93-7,MFCD00058385
Catalog No.:AA00GU59

866541-93-7 | AT-101

Pack Size
Purity
Availability
Price(USD)
Quantity
  
1mg
98%
in stock  
$99.00   $69.00
- +
5mg
98%
in stock  
$197.00   $138.00
- +
10mg
98%
in stock  
$252.00   $177.00
- +
50mg
98%
in stock  
$736.00   $515.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
Technical Information
Catalog Number:
AA00GU59
Chemical Name:
AT-101
CAS Number:
866541-93-7
Molecular Formula:
C32H34O10
Molecular Weight:
578.6064
MDL Number:
MFCD00058385
SMILES:
CC1=CC2=C(C(=C(C(=C2C(C)C)O)O)C=O)C(=C1C3=C(C4=C(C=C3C)C(=C(C(=C4C=O)O)O)C(C)C)O)O.CC(=O)O
Properties

Downstream Synthesis Route
866541-93-7   
CASUnavailable 

[1]Locationinpatent:experimentalpartZhan,Yonghua;Jia,Guangfeng;Wu,Daocheng;Xu,Yiqing;Xu,Liang[ArchivderPharmazie,2009,vol.342,#4,p.223-229]

[2]CurrentPatentAssignee:SANFORDBURNHAMPREBYSMEDICALDISCOVERYINSTITUTE-US2010/267781,2010,A1Locationinpatent:Page/Pagecolumn33;34;36

[3]CurrentPatentAssignee:NANKAIUNIVERSITY-CN105884634,2016,ALocationinpatent:Paragraph0094-0096

[4]Sumin;Ismailov;Baram[ChemistryofNaturalCompounds,1997,vol.33,#6,p.636-641]

[5]CurrentPatentAssignee:JIANGSUDUWEIBIOENGINEERINGTECH-CN115536496,2022,ALocationinpatent:Paragraph0011;0084-0088;0117-0119;0183-0185

[6]CurrentPatentAssignee:JIANGSUDUWEIBIOENGINEERINGTECH-CN115536496,2022,ALocationinpatent:Paragraph0011;0083-0088;0117-0119;0183-0185

[7]CurrentPatentAssignee:JIANGSUDUWEIBIOENGINEERINGTECH-CN115536496,2022,ALocationinpatent:Paragraph0011;0083-0088;0117-0119;0183-0185

107-35-7    866541-93-7   
CASUnavailable 

[1]Li,Ling;Li,Zheng;Wang,Kailiang;Liu,Yuxiu;Li,Yongqiang;Wang,Qingmin[BioorganicandMedicinalChemistry,2016,vol.24,#3,p.474-483]

[2]CurrentPatentAssignee:NANKAIUNIVERSITY-CN105884634,2016,ALocationinpatent:Paragraph0067-0069

[1]Li,Ling;Li,Zheng;Wang,Kailiang;Liu,Yuxiu;Li,Yongqiang;Wang,Qingmin[BioorganicandMedicinalChemistry,2016,vol.24,#3,p.474-483]

[2]CurrentPatentAssignee:NANKAIUNIVERSITY-CN105884634,2016,ALocationinpatent:Paragraph0083-0085

[1]Li,Ling;Li,Zheng;Wang,Kailiang;Liu,Yuxiu;Li,Yongqiang;Wang,Qingmin[BioorganicandMedicinalChemistry,2016,vol.24,#3,p.474-483]

[1]CurrentPatentAssignee:WUHANUNIVERSITY-CN105503627,2016,ALocationinpatent:Paragraph0051;0052;0053;0054;0055

[2]Lu,Yuzhi;Wu,Shuangchan;Yue,Yuan;He,Si;Li,Jun;Tang,Jun;Wang,Wei;Zhou,Hai-Bing[ACSMedicinalChemistryLetters,2016,vol.7,#12,p.1185-1190]

Literature

Title: Oliver CL, et al. In vitro effects of the BH3 mimetic, (-)-Gossypol, on head and neck squamous cell carcinoma cells. Clin Cancer Res. 2004 Nov 15;10(22):7757-63.

Title: Sun Y, et al. Apogossypolone, a nonpeptidic small molecule inhibitor targeting Bcl-2 family proteins, effectively inhibits growth of diffuse large cell lymphoma cells in vitro and in vivo. Cancer Biol Ther. 2008 Sep;7(9):1418-26.

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:866541-93-7 Molecular Formula|866541-93-7 MDL|866541-93-7 SMILES|866541-93-7 AT-101